These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29846236)

  • 41. Metal chelation therapy in rheumathoid arthritis: a case report. Successful management of rheumathoid arthritis by metal chelation therapy.
    Bamonti F; Fulgenzi A; Novembrino C; Ferrero ME
    Biometals; 2011 Dec; 24(6):1093-8. PubMed ID: 21655943
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chelation Therapy in Patients With Cardiovascular Disease: A Systematic Review.
    Ravalli F; Vela Parada X; Ujueta F; Pinotti R; Anstrom KJ; Lamas GA; Navas-Acien A
    J Am Heart Assoc; 2022 Mar; 11(6):e024648. PubMed ID: 35229619
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of EDTA chelation therapy in cardiovascular diseases.
    Shrihari JS; Roy A; Prabhakaran D; Reddy KS
    Natl Med J India; 2006; 19(1):24-6. PubMed ID: 16570682
    [TBL] [Abstract][Full Text] [Related]  

  • 44. So much writing, so little science: a review of 37 years of literature on edetate sodium chelation therapy.
    Grier MT; Meyers DG
    Ann Pharmacother; 1993 Dec; 27(12):1504-9. PubMed ID: 8305786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metals in medicine.
    Nash RA
    Altern Ther Health Med; 2005; 11(4):18-25. PubMed ID: 16053118
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heavy Metal Toxicity in Chronic Renal Failure and Cardiovascular Disease: Possible Role for Chelation Therapy.
    Glicklich D; Shin CT; Frishman WH
    Cardiol Rev; 2020; 28(6):312-318. PubMed ID: 32040019
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chelation trial in patients with cardiovascular disease.
    Yen TH; Yen JS
    Am Heart J; 2023 Feb; 256():1. PubMed ID: 36336079
    [No Abstract]   [Full Text] [Related]  

  • 48. Chelation therapy may improve cardiovascular health.
    BMJ; 2013 Apr; 346():f2071. PubMed ID: 23553884
    [No Abstract]   [Full Text] [Related]  

  • 49. Chelation therapy: overlooked in the treatment and prevention of diabetes complications?
    Frizzell N; Baynes JW
    Future Med Chem; 2013 Jun; 5(10):1075-8. PubMed ID: 23795964
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of chelation therapy on progressive diabetic nephropathy in patients with type 2 diabetes and high-normal body lead burdens.
    Chen KH; Lin JL; Lin-Tan DT; Hsu HH; Hsu CW; Hsu KH; Yen TH
    Am J Kidney Dis; 2012 Oct; 60(4):530-8. PubMed ID: 22721929
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Should EDTA chelation therapy be used instead of long-term clopidogrel plus aspirin to treat patients at risk from drug-eluting stents?
    Chappell LT
    Altern Med Rev; 2007 Jun; 12(2):152-8. PubMed ID: 17604460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
    Dailey G
    Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aspirin for primary prevention of cardiovascular and all-cause mortality events in diabetes: updated meta-analysis of randomized controlled trials.
    Kunutsor SK; Seidu S; Khunti K
    Diabet Med; 2017 Mar; 34(3):316-327. PubMed ID: 27086572
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiology Patient Page. Chelation therapy: a new look at an old treatment for heart disease, particularly in diabetics.
    Lamas GA
    Circulation; 2015 May; 131(21):e505-6. PubMed ID: 26015468
    [No Abstract]   [Full Text] [Related]  

  • 55. Letter to the editor concerning article "Design of the Trial to Assess Chelation Therapy (TACT)".
    Ernst E
    Am Heart J; 2012 Dec; 164(6):e23; author reply e25. PubMed ID: 23194497
    [No Abstract]   [Full Text] [Related]  

  • 56. Chelation therapy for cardiovascular disease. Review and commentary.
    Lewin MR
    Tex Heart Inst J; 1997; 24(2):81-9. PubMed ID: 9205980
    [No Abstract]   [Full Text] [Related]  

  • 57. Evaluation of the Trial to Assess Chelation Therapy (TACT): the scientific process, peer review, and editorial scrutiny.
    Bauchner H; Fontanarosa PB; Golub RM
    JAMA; 2013 Mar; 309(12):1291-2. PubMed ID: 23532245
    [No Abstract]   [Full Text] [Related]  

  • 58. The proceedings of the 20th International Conference on Chelation held in the USA: advances on new and old chelation therapies.
    Kontoghiorghes GJ
    Toxicol Mech Methods; 2013 Jan; 23(1):1-4. PubMed ID: 22900514
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EDTA chelation therapy in the treatment of vascular disease.
    Chappell LT; Janson M
    J Cardiovasc Nurs; 1996 Apr; 10(3):78-86. PubMed ID: 8820322
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chelation therapy for coronary heart disease: An overview of all clinical investigations.
    Ernst E
    Am Heart J; 2000 Jul; 140(1):139-41. PubMed ID: 10874275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.